Dextech Medical AB (XSAT:DEX)
Sweden flag Sweden · Delayed Price · Currency is SEK
10.35
+0.05 (0.49%)
At close: Aug 26, 2026

Dextech Medical AB Financials Overview

Millions SEK. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
4.153.225.398.713.120.63
Revenue Growth
-2.06%-40.15%-38.18%179.60%390.65%6.48%
Gross Profit
4.13.225.398.713.120.63
Operating Income
-6.34-5.32-5.55-4.94-5.27-6.08
Net Income
-6.12-4.84-4.71-4.59-5.27-6.08
Earnings Per Share
-0.33-0.26-0.25-0.25-0.31-0.41
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Cash (Debt)
10.1214.7119.0425.2435.473.46
Net Cash Growth
-35.14%-22.76%-24.54%-28.86%926.20%-43.25%
Net Cash Per Share
0.540.791.011.372.090.23
Cash & Investments
10.1214.7119.0425.2435.473.46

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-1.33-1.11-0.81-1.55-2-2
Free Cash Flow
-1.33-1.11-0.81-1.55-2-2
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
98.70%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-152.78%-165.01%-103.04%-56.70%-169.14%-956.76%
Pretax Margin
-147.41%-150.32%-87.38%-52.70%-169.14%-956.77%
Profit Margin
-147.42%-150.31%-87.38%-52.70%-169.14%-956.77%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
46.0843.0214.568.9128.60810.67